Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUNIC, INC. Director's Dealing 2015

Oct 27, 2015

10196_dirs_2015-10-27_13a00f8d-a4df-4128-a2b5-0ee339597f54.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2015-10-26

Reporting Person: Cohen Cheryl (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-10-26 Common Stock P 3500 $7.1685 Acquired 3500 Indirect

Footnotes

F1: Shares held by Cheryl L. Cohen Trust U/A 04/01/05 Cheryl L. Cohen Trustee.